AskVantage

AI and intelligence

Diagnosing Type 2 diabetes is now as easy as taking a selfie

Diabetes is a killer, and the earlier people can detect it the sooner they can seek potentially life saving treatment and advice.

Key takeaways

  • The first step was to develop a deep learning algorithm that could wade through millions of PPG recordings and find out whether this biomarker could effectively identify subjects with diabetes from healthy subjects.
  • The deep neural network examined 2.6 million PPG recordings from 53,870 individuals with diagnosed diabetes.
  • The system accurately detected diabetes in around 80 percent of subjects.
Cite or link to this article

Griffin, M. (2020) 'Diagnosing Type 2 diabetes is now as easy as taking a selfie', 311 Institute, 7 September. Available at: https://www.311institute.com/diagnosing-type-2-diabetes-is-now-as-easy-as-taking-a-selfie/ (Accessed: 1 October 2026).

Forget about calling your smartphone a smartphone because it’s got more in common now with medical tricorders, of the sci fi kind – and increasingly we can use it to help democratise access to healthcare for the billion or so people on the planet who today still don’t have quick access to doctors.

As I’ve written about before your pocket tricorder now has the power to diagnose everything from ADHD, cancer, coronavirus, and heart disease, through to the onset of dementia, eye disease, and PTSD – all for starters. Now though, and as if that wasn’t enough, it has a new trick – it can detect the onset of diabetes after a team from the University of California, San Francisco (UCSF) demonstrated using Artificial Intelligence (AI) and a simple smartphone camera to diagnose type 2 diabetes with an 80 percent accuracy.

“Diabetes can be asymptomatic for a long period of time, making it much harder to diagnose,” says lead author on the new study, Robert Avram. “To date, non-invasive and widely-scalable tools to detect diabetes have been lacking, motivating us to develop this algorithm.”

The new innovation is based on Photoplethysmography (PPG), a technique where light can be shone into tissue to detect blood volume changes. PPG is perhaps most commonly known for the little finger clamp doctors use to measure heart rate and blood oxygen levels.

As soon as smartphone cameras appeared a decade ago, researchers immediately suggested the devices should be able to capture PPG measurements. In this study, the researchers hypothesized PPG data, captured by a smartphone camera, may be able to detect vascular damage caused by diabetes.

The first step was to develop a deep learning algorithm that could wade through millions of PPG recordings and find out whether this biomarker could effectively identify subjects with diabetes from healthy subjects. The deep neural network examined 2.6 million PPG recordings from 53,870 individuals with diagnosed diabetes.

After developing the algorithm, the researchers tested its ability to detect diabetes solely from smartphone PPG data in three separate cohorts, gathered using the device's flashlight and camera applied to the patient's fingertips. The system accurately detected diabetes in around 80 percent of subjects. The predictive potential of the algorithm improved even further when it was combined with other basic patient data such as body mass index and age.

“We demonstrated that the algorithm’s performance is comparable to other commonly used tests, such as mammography for breast cancer or cervical cytology for cervical cancer, and its painlessness makes it attractive for repeated testing,” suggests Jeffrey Olgin, another author on the new study. “A widely accessible smartphone-based tool like this could be used to identify and encourage individuals at higher risk of having prevalent diabetes to seek medical care and obtain a low-cost confirmatory test.”

It will be some time before the work effectively translates into some kind of diabetes-detecting app for your smartphone, however, this is an incredibly promising proof-of-concept development. The researchers are cautious to note the next steps will be to determine how this particular digital tool can be best incorporated into existing diabetes screening practices.

“The ability to detect a condition like diabetes that has so many severe health consequences using a painless, smartphone-based test raises so many possibilities,” says co-senior author Geoffrey Tison. “The vision would be for a tool like this to assist in identifying people at higher risk of having diabetes, ultimately helping to decrease the prevalence of undiagnosed diabetes.”

The new study was published in the journal Nature Medicine.

Source: UC San Francisco

FAQ

Why does this matter?

Diabetes is a killer, and the earlier people can detect it the sooner they can seek potentially life saving treatment and advice.

Matthew Griffin

About the author

Matthew Griffin Founder, 311 Institute

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."

Read full bio

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.

What future do you need to see?

Choose one to get started on AI and intelligence and the future of your organisation.

Where should Matthew reply?

Takes 30 seconds. No obligation. Matthew replies quickly. Privacy

Tag Cloud

Sources and further reading

  1. Photoplethysmogram en.wikipedia.org
  2. immediately suggested ieeexplore.ieee.org
  3. S41591 020 1010 5 nature.com
  4. UC San Francisco ucsf.edu

Source: first published by the 311 Institute on 7 September 2020. Cite as: Griffin, M. (2020). Diagnosing Type 2 diabetes is now as easy as taking a selfie. 311 Institute. https://www.311institute.com/diagnosing-type-2-diabetes-is-now-as-easy-as-taking-a-selfie/

You are welcome to quote this article with credit and a link to the original.

Book a Keynote